Lee Ainslie Abiomed Inc Transaction History

Maverick Capital LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $244,187 - $303,570	1,007 New	1,007 $247,000
Q1 2022 May 16, 2022	BUY	$277.25 - $366.29 $136,961 - $180,947	494 Added 165.77%	792 $262,000
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $1.52 Million - $1.87 Million	-5,049 Reduced 94.43%	298 $107,000
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $777,956 - $943,509	-2,508 Reduced 31.93%	5,347 $1.74 Million
Q2 2021 Aug 16, 2021	BUY	$262.71 - $351.17 $1.3 Million - $1.74 Million	4,966 Added 171.89%	7,855 $2.45 Million
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $903,221 - $1.12 Million	-3,159 Reduced 52.23%	2,889 $921,000
Q4 2020 Feb 16, 2021	BUY	$251.88 - $324.2 $880,068 - $1.13 Million	3,494 Added 136.81%	6,048 $1.96 Million
Q3 2020 Nov 16, 2020	SELL	$255.22 - $317.0 $1.89 Million - $2.35 Million	-7,419 Reduced 74.39%	2,554 $708,000
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $1.41 Million - $2.56 Million	9,973 New	9,973 $2.41 Million
Q1 2018 May 15, 2018	SELL	$192.49 - $295.85 $6.27 Million - $9.64 Million	-32,580 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$168.78 - $199.74 $5.5 Million - $6.51 Million	32,580	32,580 $6.11 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.